Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label,... von Al-Sawaf, Othman, Zhang, Can, Tandon, Maneesh, Sinha, Arijit, Fink, Anna-Maria, Robrecht, Sandra, Samoylova, Olga, Liberati, Anna M, Pinilla-Ibarz, Javier, Opat, Stephen, Sivcheva, Liliya, Le Dû, Katell, Fogliatto, Laura M, Niemann, Carsten U, Weinkove, Robert, Robinson, Sue, Kipps, Thomas J, Tausch, Eugen, Schary, William, Ritgen, Matthias, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Eichhorst, Barbara, Stilgenbauer, Stephan, Hallek, Michael, Fischer, Kirsten

Volltext

Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection von Drosten, Christian, Prof, Seilmaier, Michael, MD, Corman, Victor M, MD, Hartmann, Wulf, MD, Scheible, Gregor, MD, Sack, Stefan, Prof, Guggemos, Wolfgang, MD, Kallies, Rene, PhD, Muth, Doreen, PhD, Junglen, Sandra, PhD, Müller, Marcel A, PhD, Haas, Walter, MD, Guberina, Hana, MD, Röhnisch, Tim, MD, Schmid-Wendtner, Monika, Prof, Aldabbagh, Souhaib, DVM, Dittmer, Ulf, Prof, Gold, Hermann, MD, Graf, Petra, MD, Bonin, Frank, MD, Rambaut, Andrew, DPhil, Wendtner, Clemens-Martin, Prof

Volltext

CLL: deep dive for residual cells by NGS matters von Wendtner, Clemens-Martin

Volltext

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study von Stilgenbauer, Stephan, Prof, Eichhorst, Barbara, Prof, Schetelig, Johannes, Prof, Coutre, Steven, Prof, Seymour, John F, Prof, Munir, Talha, Prof, Puvvada, Soham D, MD, Wendtner, Clemens-Martin, Prof, Roberts, Andrew W, Prof, Jurczak, Wojciech, Prof, Mulligan, Stephen P, Prof, Böttcher, Sebastian, MD, Mobasher, Mehrdad, MD, Zhu, Ming, PhD, Desai, Monali, MD, Chyla, Brenda, PhD, Verdugo, Maria, MD, Enschede, Sari Heitner, MD, Cerri, Elisa, MD, Humerickhouse, Rod, MD, Gordon, Gary, MD, Hallek, Michael, Prof, Wierda, William G, MD

Volltext

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): a... von Eichhorst, Barbara, Dr, Fink, Anna-Maria, MD, Bahlo, Jasmin, PhD, Busch, Raymonde, Dipl Math, Kovacs, Gabor, MD, Maurer, Christian, MD, Lange, Elisabeth, MD, Köppler, Hubert, Prof, Kiehl, Michael, Prof, Sökler, Martin, MD, Schlag, Rudolf, MD, Vehling-Kaiser, Ursula, MD, Köchling, Georg, MD, Plöger, Christoph, MD, Gregor, Michael, MD, Plesner, Torben, MD, Trneny, Marek, Prof, Fischer, Kirsten, MD, Döhner, Harmut, Prof, Kneba, Michael, Prof, Wendtner, Clemens-Martin, Prof, Klapper, Wolfram, Prof, Kreuzer, Karl-Anton, Prof, Stilgenbauer, Stephan, Prof, Böttcher, Sebastian, MD, Hallek, Michael, Prof

Volltext

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia von Eichhorst, Barbara, Niemann, Carsten U., Kater, Arnon P., Fürstenau, Moritz, von Tresckow, Julia, Zhang, Can, Robrecht, Sandra, Gregor, Michael, Juliusson, Gunnar, Thornton, Patrick, Staber, Philipp B., Tadmor, Tamar, Lindström, Vesa, da Cunha-Bang, Caspar, Schneider, Christof, Poulsen, Christian B., Illmer, Thomas, Schöttker, Björn, Nösslinger, Thomas, Janssens, Ann, Christiansen, Ilse, Baumann, Michael, Frederiksen, Henrik, van der Klift, Marjolein, Jäger, Ulrich, Leys, Maria B.L., Hoogendoorn, Mels, Lotfi, Kourosh, Hebart, Holger, Gaska, Tobias, Koene, Harry, Enggaard, Lisbeth, Goede, Jereon, Regelink, Josien C., Widmer, Anouk, Simon, Florian, De Silva, Nisha, Fink, Anna-Maria, Bahlo, Jasmin, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl A., Ritgen, Matthias, Brüggemann, Monika, Tausch, Eugen, Levin, Mark-David, van Oers, Marinus, Geisler, Christian, Stilgenbauer, Stephan, Hallek, Michael

Volltext

High variability of COVID-19 case fatality rate in Germany von Wjst, Matthias, Wendtner, Clemens

Volltext

Ibrutinib: the home run for cure in CLL? von Wendtner, Clemens-Martin

Volltext

Clinical and virological features of first human monkeypox cases in Germany von Noe, Sebastian, Zange, Sabine, Seilmaier, Michael, Antwerpen, Markus H., Fenzl, Thomas, Schneider, Jochen, Spinner, Christoph D., Bugert, Joachim J., Wendtner, Clemens-Martin, Wölfel, Roman

Volltext

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial von Fischer, Kirsten, Bahlo, Jasmin, Fink, Anna Maria, Goede, Valentin, Herling, Carmen Diana, Cramer, Paula, Langerbeins, Petra, von Tresckow, Julia, Engelke, Anja, Maurer, Christian, Kovacs, Gabor, Herling, Marco, Tausch, Eugen, Kreuzer, Karl-Anton, Eichhorst, Barbara, Böttcher, Sebastian, Seymour, John F., Ghia, Paolo, Marlton, Paula, Kneba, Michael, Wendtner, Clemens-Martin, Döhner, Hartmut, Stilgenbauer, Stephan, Hallek, Michael

Volltext

Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial von Cramer, Paula, von Tresckow, Julia, Bahlo, Jasmin, Robrecht, Sandra, Langerbeins, Petra, Al-Sawaf, Othman, Engelke, Anja, Fink, Anna-Maria, Fischer, Kirsten, Tausch, Eugen, Seiler, Till, Fischer von Weikersthal, Ludwig, Hebart, Holger, Kreuzer, Karl-Anton, Böttcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Eichhorst, Barbara, Hallek, Michael

Volltext

Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy von Pallasch, Christian P., Leskov, Ilya, Braun, Christian J., Vorholt, Daniela, Drake, Adam, Soto-Feliciano, Yadira M., Bent, Eric H., Schwamb, Janine, Iliopoulou, Bettina, Kutsch, Nadine, van Rooijen, Nico, Frenzel, Lukas P., Wendtner, Clemens M., Heukamp, Lukas, Kreuzer, Karl Anton, Hallek, Michael, Chen, Jianzhu, Hemann, Michael T.

Volltext

Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study von Al-Sawaf, Othman, Zhang, Can, Lu, Tong, Liao, Michael Z, Panchal, Anesh, Robrecht, Sandra, Ching, Travers, Tandon, Maneesh, Fink, Anna-Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Böttcher, Sebastian, Kreuzer, Karl-Anton, Chyla, Brenda, Miles, Dale, Wendtner, Clemens-Martin, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten

Volltext

Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia von Herling, Carmen D., Abedpour, Nima, Weiss, Jonathan, Schmitt, Anna, Jachimowicz, Ron Daniel, Merkel, Olaf, Cartolano, Maria, Oberbeck, Sebastian, Mayer, Petra, Berg, Valeska, Thomalla, Daniel, Kutsch, Nadine, Stiefelhagen, Marius, Cramer, Paula, Wendtner, Clemens-Martin, Persigehl, Thorsten, Saleh, Andreas, Altmüller, Janine, Nürnberg, Peter, Pallasch, Christian, Achter, Viktor, Lang, Ulrich, Eichhorst, Barbara, Castiglione, Roberta, Schäfer, Stephan C., Büttner, Reinhard, Kreuzer, Karl-Anton, Reinhardt, Hans Christian, Hallek, Michael, Frenzel, Lukas P., Peifer, Martin

Volltext

Use of eculizumab in refractory gemcitabine‐induced thrombotic microangiopathy von Starck, Michael, Wendtner, Clemens‐Martin

Volltext

Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial von Stilgenbauer, Stephan, Eichhorst, Barbara, Schetelig, Johannes, Hillmen, Peter, Seymour, John F, Coutre, Steven, Jurczak, Wojciech, Mulligan, Stephen P, Schuh, Anna, Assouline, Sarit, Wendtner, Clemens-Martin, Roberts, Andrew W, Davids, Matthew S, Bloehdorn, Johannes, Munir, Talha, Böttcher, Sebastian, Zhou, Lang, Salem, Ahmed Hamed, Desai, Monali, Chyla, Brenda, Arzt, Jennifer, Kim, Su Young, Verdugo, Maria, Gordon, Gary, Hallek, Michael, Wierda, William G

Volltext

A novel hierarchical prognostic model of AML solely based on molecular mutations von Grossmann, Vera, Schnittger, Susanne, Kohlmann, Alexander, Eder, Christiane, Roller, Andreas, Dicker, Frank, Schmid, Christoph, Wendtner, Clemens-Martin, Staib, Peter, Serve, Hubert, Kreuzer, Karl-Anton, Kern, Wolfgang, Haferlach, Torsten, Haferlach, Claudia

Volltext

Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia von Ecker, Veronika, Stumpf, Martina, Brandmeier, Lisa, Neumayer, Tanja, Pfeuffer, Lisa, Engleitner, Thomas, Ringshausen, Ingo, Nelson, Nina, Jücker, Manfred, Wanninger, Stefan, Zenz, Thorsten, Wendtner, Clemens, Manske, Katrin, Steiger, Katja, Rad, Roland, Müschen, Markus, Ruland, Jürgen, Buchner, Maike

Volltext

Bendamustine plus rituximab in chronic lymphocytic leukemia: is there life in the old dog yet? von Wendtner, Clemens-Martin

Volltext

Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Rando... von BÖTTCHER, Sebastian, RITGEN, Matthias, MENDILA, Myriam, WENDTNER, Clemens-Martin, EICHHORST, Barbara F, DÖHNER, Hartmut, HALLEK, Michael J, KNEBA, Michael, FISCHER, Kirsten, STILGENBAUER, Stephan, BUSCH, Raymonde M, FINGERLE-ROWSON, Günter, FINK, Anna Maria, BÜHLER, Andreas, ZENZ, Thorsten, WENGER, Michael Karl

Volltext